The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
Open accessAbstract
Background: Observational and small, randomized studies suggest that influenza vaccine may reduce future cardiovascular events in patients with cardiovascular disease. Methods: We conducted an investigator-initiated, randomized, double-blind trial to compare inactivated influenza vaccine with saline placebo administered shortly after myocardial infarction (MI; 99.7% of patients) or high-risk stable coronary heart disease (0.3%). The primary end point was the composite of all-cause death, MI, or stent thrombosis at 12 months. A hierarchical testing strategy was used for the key secondary end points: all-cause death, cardiovascular death, MI, and stent thrombosis. Results: Because of the COVID-19 pandemic, the data safety and monitoring board recommended to halt the trial before attaining the prespecified sample size. Between October 1, 2016, and March 1, 2020, 2571 participants were randomized at 30 centers across 8 countries. Participants assigned to influenza vaccine totaled 1290 and individuals assigned to placebo equaled 1281; of these, 2532 received the study treatment (1272 influenza vaccine and 1260 placebo) and were included in the modified intention to treat analysis. Over the 12-month follow-up, the primary outcome occurred in 67 participants (5.3%) assigned influenza vaccine and 91 participants (7.2%) assigned placebo (hazard ratio, 0.72 [95% CI, 0.52–0.99]; P =0.040). Rates of all-cause death were 2.9% and 4.9% (hazard ratio, 0.59 [95% CI, 0.39–0.89]; P =0.010), rates of cardiovascular death were 2.7% and 4.5%, (hazard ratio, 0.59 [95% CI, 0.39–0.90]; P =0.014), and rates of MI were 2.0% and 2.4% (hazard ratio, 0.86 [95% CI, 0.50–1.46]; P =0.57) in the influenza vaccine and placebo groups, respectively. Conclusions: Influenza vaccination early after an MI or in high-risk coronary heart disease resulted in a lower risk of a composite of all-cause death, MI, or stent thrombosis, and a lower risk of all-cause death and cardiovascular death, as well, at 12 months compared with placebo. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02831608.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination
Smeeth, L., Thomas, S. L., Hall, A. J., Hubbard, R., Farrington, P., & Vallance, P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041747 · Cited by 1,375
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
Kwong, J. C., Schwartz, K. L., Campitelli, M. A., Chung, H., Crowcroft, N. S., Karnauchow, T., Katz, K., Ko, D. T., McGeer, A. J., McNally, D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1702090 · Cited by 1,199
Inflammation, Immunity, and Infection in Atherothrombosis
Libby, P., Loscalzo, J., Ridker, P. M., Farkouh, M. E., Hsue, P. Y., Fuster, V., Hasan, A. A., & Amar, S. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.1043 · Cited by 548
Udell, J. A., Zawi, R., Bhatt, D. L., Keshtkar-Jahromi, M., Gaughran, F., Phrommintikul, A., Ciszewski, A., Vakili, H., Hoffman, E. B., Farkouh, M. E., et al. (2013) · JAMA · doi:10.1001/jama.2013.279206 · Cited by 516
Gurfinkel, E. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.018 · Cited by 268
Ciszewski, A., Bilinska, Z. T., Brydak, L. B., Kepka, C., Kruk, M., Romanowska, M., Ksiezycka, E., Przyluski, J., Piotrowski, W., Maczynska, R., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehm581 · Cited by 264
When to stop a clinical trial.
Pocock, S. J. (1992) · BMJ · doi:10.1136/bmj.305.6847.235 · Cited by 255
Self-citationInfluenza vaccination reduces cardiovascular events in patients with acute coronary syndrome
Phrommintikul, A., Kuanprasert, S., Wongcharoen, W., Kanjanavanit, R., Chaiwarith, R., & Sukonthasarn, A. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr004 · Cited by 246
Influenza Vaccination as Secondary Prevention for Cardiovascular Disease
Davis, M. M., Taubert, K., Benin, A. L., Brown, D. W., Mensah, G. A., Baddour, L. M., Dunbar, S., & Krumholz, H. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.004 · Cited by 235
Bucasas, K. L., Franco, L. M., Shaw, C. A., Bray, M. S., Wells, J. M., Niño, D., Arden, N., Quarles, J. M., Couch, R. B., & Belmont, J. W. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq156 · Cited by 229
Influenza vaccines for preventing cardiovascular disease
Clar, C., Oseni, Z., Flowers, N., Keshtkar-Jahromi, M., & Rees, K. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005050.pub3 · Cited by 214
Warren-Gash, C., Hayward, A. C., Hemingway, H., Denaxas, S., Thomas, S. L., Timmis, A. D., Whitaker, H., & Smeeth, L. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis597 · Cited by 205
Excess Mortality from Causes Other than Influenza and Pneumonia during Influenza Epidemics
Collins, S. D. (1932) · Public Health Reports (1896-1970) · doi:10.2307/4580606 · Cited by 198
Yedlapati, S. H., Khan, S. U., Talluri, S., Lone, A. N., Khan, M. Z., Khan, M. S., Navar, A. M., Gulati, M., Johnson, H., Baum, S., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019636 · Cited by 175
Population Trends in Percutaneous Coronary Intervention
Fokkema, M. L., James, S. K., Albertsson, P., Akerblom, A., Calais, F., Eriksson, P., Jensen, J., Nilsson, T., de Smet, B. J., Sjögren, I., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.007 · Cited by 170
Self-citationMuhlestein, J. B., Horne, B. D., Bair, T. L., Li, Q., Madsen, T. E., Pearson, R. R., & Anderson, J. L. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01354-0 · Cited by 159
Vardeny, O., Kim, K., Udell, J. A., Joseph, J., Desai, A. S., Farkouh, M. E., Hegde, S. M., Hernandez, A. F., McGeer, A., Talbot, H. K., et al. (2020) · JAMA · doi:10.1001/jama.2020.23649 · Cited by 149
The impact of medication adherence on clinical outcomes of coronary artery disease: A meta-analysis
Du, L., Cheng, Z., Zhang, Y., Li, Y., & Mei, D. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317695628 · Cited by 138
Rondy, M., Kissling, E., Emborg, H., Gherasim, A., Pebody, R. G., Trebbien, R., Pozo, F., Larrauri, A., McMenamin, J., Valenciano, M., et al. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.9.18-00086 · Cited by 134
Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study
MacIntyre, C. R., Heywood, A. E., Kovoor, P., Ridda, I., Seale, H., Tan, T. C., Gao, Z., Katelaris, A. L., Siu, D. H. W., Lo, V., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-304320 · Cited by 97
Self-citationInterim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
Kissling, E., Rose, A., Emborg, H., Gherasim, A., Pebody, R. G., Pozo, F., Trebbien, R., Mazagatos, C., Whitaker, H., Valenciano, M., et al. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.1900121 · Cited by 77
Gwini, S. M., Coupland, C. A. C., & Siriwardena, A. N. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.12.017 · Cited by 73
Rose, A. M., Kissling, E., Emborg, H., Larrauri, A., McMenamin, J., Pozo, F., Trebbien, R., Mazagatos, C., Whitaker, H., Valenciano, M., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.10.2000153 · Cited by 66
Influenza vaccination promotes stable atherosclerotic plaques in apoE knockout mice
Bermúdez-Fajardo, A., & Oviedo‐Orta, E. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.019 · Cited by 59
Considering Cause and Effect of Immune Cell Aging on Cardiac Repair after Myocardial Infarction
Tobin, S. W., Alibhai, F. J., Weisel, R. D., & Li, R. (2020) · Cells · doi:10.3390/cells9081894 · Cited by 35
Association of acute myocardial infarction with influenza: A nationwide observational study
Mohammad, M. A., Tham, J., Koul, S. M., Rylance, R., Bergh, C., Erlinge, D., & Fröbert, O. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236866 · Cited by 20
Self-citation
Cited by
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
Diagnosis and Treatment of Acute Coronary Syndromes: A Review
Bhatt, D. L., Lopes, R. D., & Harrington, R. A. (2022) · JAMA · doi:10.1001/jama.2022.0358 · Cited by 787
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001309 · Cited by 625
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · JACC · doi:10.1016/j.jacc.2024.11.009 · Cited by 552
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2024) · European Heart Journal: Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad107 · Cited by 314
Self-citation
Metadata
- Authors
- Fröbert, O., Götberg, M., Erlinge, D., Akhtar, Z., Christiansen, E. H., MacIntyre, C. R., Oldroyd, K. G., Motovska, Z., Erglis, A., Moer, R., Hlinomaz, O., Jakobsen, L., Engstrøm, T., Jensen, L. O., Fallesen, C. O., Jensen, S. E., Angerås, O., Calais, F., Kåregren, A., Lauermann, J., Mokhtari, A., Nilsson, J., Persson, J., Stalby, P., Islam, A. K. M. M., Rahman, A., Malik, F., Choudhury, S., Collier, T., Pocock, S. J., & Pernow, J.
- Venue
- Circulation
- Published
- 2021-11-02
- Volume
- 144
- Issue
- 18
- Pages
- 1476-1484
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3197803928
- Cited by
- 272
- References
- 27
- FWCI
- 25.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.